<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30186747</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2211-5463</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>FEBS open bio</Title><ISOAbbreviation>FEBS Open Bio</ISOAbbreviation></Journal><ArticleTitle>MicroR-9-5p suppresses EV71 replication through targeting NF&#x3ba;B of the RIG-I-mediated innate immune response.</ArticleTitle><Pagination><StartPage>1457</StartPage><EndPage>1470</EndPage><MedlinePgn>1457-1470</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/2211-5463.12490</ELocationID><Abstract><AbstractText>Accumulating evidence demonstrates that there is a causative link between hsa-microRNA-9-5p (miR-9) and pathophysiological processes. Enterovirus 71 (EV71) has been found to contribute to numerous severe clinical symptoms which result in death. The exact mechanism by which EV71 influences miR-9 expression is unknown, and the relationship between miR-9 and EV71 is still unclear. Here, miR-9 expression was found to be impaired upon EV71 infection in several cell lines and in an EV71 infection mouse model. Additionally, we confirmed that EV71 infection induces robust expression of pro-inflammatory cytokines (TNF-&#x3b1;, IL-6, and IL-1) and interferons (IFN-&#x3b1; and IFN-&#x3b2;). Overexpression of miR-9 attenuated EV71 proliferation and reduced protein and gene expressions of virion protein 1 (VP1) of EV71. Furthermore, we observed that the inflammation caused by EV71 infection was restored to a moderate level via miR-9 overexpression. Nuclear factor kappa B (NF&#x3ba;B) in the retinoic acid-induced gene 1 (RIG-I) signaling pathway, but not interferon regulating factor 3 (IRF3), was significantly decreased and inactivated by ectopic miR-9 expression. Moreover, in mouse infection experiments, administration of miR-9 agomirs caused a significant decrease in VP1 levels and pro-inflammatory cytokine production after viral inoculation. Taken together, the present data demonstrate that miR-9 exerts an anti-EV71 effect in cells and a mouse model via mediating NF&#x3ba;B activity of the RIG-I signal pathway, thereby suggesting a new candidate for antiviral drug development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Jinan Maternity and Child Care Hospital China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Junqing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Jinan Maternity and Child Care Hospital China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016441">Retracted Publication</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>FEBS Open Bio</MedlineTA><NlmUniqueID>101580716</NlmUniqueID><ISSNLinking>2211-5463</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="RetractionIn"><RefSource>FEBS Open Bio. 2023 Apr;13(4):795. doi: 10.1002/2211-5463.13583</RefSource><PMID Version="1">36929634</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">NF&#x3ba;B</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">miR&#x2010;9</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30186747</ArticleId><ArticleId IdType="pmc">PMC6120239</ArticleId><ArticleId IdType="doi">10.1002/2211-5463.12490</ArticleId><ArticleId IdType="pii">FEB412490</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lui YL, Lin Z, Lee JJ, Chow VT, Poh CL and Tan EL (2013) Beta&#x2010;actin variant is necessary for Enterovirus 71 replication. Biochem Biophys Res Commun 433, 607&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">23535377</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC (2012) Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol 2, 199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KP and Bergelson JM (2009) Receptors identified for hand, foot and mouth virus. Nat Med 15, 728&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">19584857</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SS, Yip CC, Lau SK and Yuen KY (2010) Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 138, 1071&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho BC, Yu SL, Chen JJ, Chang SY, Yan BS, Hong QS, Singh S, Kao CL, Chen HY, Su KY et al (2011) Enterovirus&#x2010;induced miR&#x2010;141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 9, 58&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">21238947</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Weng KF and Shih SR (2012) Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol 7, 467&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">22439724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang W, Zhang Y, Yan L, Wang S, Zhang J, Sun J, Chang Z and Wang Z (2014) Clinical features of severe cases of hand, foot and mouth disease with EV71 virus infection in China. Arch Med Sci 10, 510&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107257</ArticleId><ArticleId IdType="pubmed">25097582</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatproedprai S, Tempark T, Wanlapakorn N, Puenpa J, Wananukul S and Poovorawan Y (2015) Unusual skin manifestation of hand, foot and mouth disease associated with coxsackievirus A6: cases report. Springerplus 4, 362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4504872</ArticleId><ArticleId IdType="pubmed">26203408</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Ho MS, Lin KH, Wu SL, Chen YT, Wu CN, Lin TY, Chang LY, Tsao KC, Ning HC et al (2000) Genetic analysis of enterovirus 71 isolated from fatal and non&#x2010;fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res 68, 127&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">10958984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Hsia SH, Huang YC, Wu CT and Chang LY (2003) Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis 36, 269&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham AC, Hilmer KM, Zickovich JM and Obar JJ (2013) Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG&#x2010;I signaling. J Immunol 190, 4676&#x2013;4684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3633673</ArticleId><ArticleId IdType="pubmed">23526820</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinya K, Okamura T, Sueta S, Kasai N, Tanaka M, Ginting TE, Makino A, Eisfeld AJ and Kawaoka Y (2011) Toll&#x2010;like receptor pre&#x2010;stimulation protects mice against lethal infection with highly pathogenic influenza viruses. Virol J 8, 97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3061943</ArticleId><ArticleId IdType="pubmed">21375734</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates BM, Staricha KL, Ravindran N, Koch CM, Cheng Y, Davis JM, Shumaker DK and Ridge KM (2017) Inhibition of the NOD&#x2010;Like Receptor Protein 3 Inflammasome Is Protective in Juvenile Influenza A Virus Infection. Front Immunol 8, 782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5502347</ArticleId><ArticleId IdType="pubmed">28740490</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth RB, Sun L, Ea CK and Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF&#x2010;kappaB and IRF 3. Cell 122, 669&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kido H (2015) Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options. Proc Jpn Acad Ser B Phys Biol Sci 91, 351&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729853</ArticleId><ArticleId IdType="pubmed">26460316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee RC, Feinbaum RL &amp; Ambros V. The C (1993) elegans heterochronic gene lin&#x2010;4 encodes small RNAs with antisense complementarity to lin&#x2010;14. Cell 75: 843&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">8252621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yang L, Liang X and Zhu G (2015) MicroRNA&#x2010;155 promotes atherosclerosis inflammation via targeting SOCS1. Cell Physiol Biochem 36, 1371&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pubmed">26159489</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Qiu J, Li C, Qiu Y, Guo L, Liu Y, Wan J, Li Y, Wu G, Wang L et al (2018) Fortunellin&#x2010;induced modulation of phosphatase and tensin homolog by MicroRNA&#x2010;374a decreases inflammation and maintains intestinal barrier function in colitis. Front Immunol 9, 83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810275</ArticleId><ArticleId IdType="pubmed">29472916</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu W, Zhan H, Zhou XY, Yao L, Yan M, Chen A, Liu J, Ren X, Zhang X, Liu JX et al (2017) MicroRNA&#x2010;22 regulates inflammation and angiogenesis via targeting VE&#x2010;cadherin. FEBS Lett 591, 513&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">28112401</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson K, Malmhall C, Ramos&#x2010;Ramirez P and Radinger M (2017) MicroRNA&#x2010;155 is a critical regulator of type 2 innate lymphoid cells and IL&#x2010;33 signaling in experimental models of allergic airway inflammation. J Allergy Clin Immunol 139 (1007&#x2013;1016), e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27492144</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsen TA, de Souza GA, Odegaard B, Engebretsen L and Brinchmann JE (2016) microRNA&#x2010;140 inhibits inflammation and stimulates chondrogenesis in a model of interleukin 1beta&#x2010;induced osteoarthritis. Mol Ther Nucleic Acids 5, e373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5095680</ArticleId><ArticleId IdType="pubmed">27727249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv F, Huang Y, Lv W, Yang L, Li F, Fan J and Sun J (2017) MicroRNA&#x2010;146a ameliorates inflammation via TRAF6/NF&#x2010;kappaB pathway in intervertebral disc cells. Med Sci Monit 23, 659&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5308543</ArticleId><ArticleId IdType="pubmed">28161709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Song J, Liu L, Li J, Tang B, Wang J, Zhang X, Zhang Y, Wang L, Liao Y et al (2016) Different microRNA alterations contribute to diverse outcomes following EV71 and CA16 infections: Insights from high&#x2010;throughput sequencing in rhesus monkey peripheral blood mononuclear cells. Int J Biochem Cell Biol 81, 20&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">27765603</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Hu Y, Li J, Zheng H, Wang J, Guo L, Ning R, Li H, Yang Z, Fan H et al (2017) Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high&#x2010;throughput sequencing. PLoS ONE 12, e0177657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439704</ArticleId><ArticleId IdType="pubmed">28531227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen BP, Dai HJ, Yang YH, Zhuang Y and Sheng R (2013) MicroRNA&#x2010;23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology 56, 195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">23594713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui YL, Tan TL, Woo WH, Timms P, Hafner LM, Tan KH and Tan EL (2014) Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection. PLoS ONE 9, e102997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105423</ArticleId><ArticleId IdType="pubmed">25047717</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Zhang L, Zhang F, Tang T, Zhou Q, Feng C, Jin Y and Wu Z (2017) Exosome&#x2010;mediated miR&#x2010;146a transfer suppresses type I interferon response and facilitates EV71 infection. PLoS Pathog 13, e1006611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5614653</ArticleId><ArticleId IdType="pubmed">28910400</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathinayake PS, Hsu AC and Wark PA (2015) Innate immunity and immune evasion by enterovirus 71. Viruses 7, 6613&#x2013;6630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeuerle PA and Baltimore D (1996) NF&#x2010;kappa B: ten years after. Cell 87, 13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">8858144</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahl HL (1999) Activators and target genes of Rel/NF&#x2010;kappaB transcription factors. Oncogene 18, 6853&#x2013;6866.</Citation><ArticleIdList><ArticleId IdType="pubmed">10602461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiscott J, Nguyen TL, Arguello M, Nakhaei P and Paz S (2006) Manipulation of the nuclear factor&#x2010;kappaB pathway and the innate immune response by viruses. Oncogene 25, 6844&#x2013;6867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100320</ArticleId><ArticleId IdType="pubmed">17072332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li H, Zhang Z, Meng J, Mao D, Bai B, Lu B, Mao P, Hu Q and Wang H (2011) Enterovirus 71 2C protein inhibits TNF&#x2010;alpha&#x2010;mediated activation of NF&#x2010;kappaB by suppressing IkappaB kinase beta phosphorylation. J Immunol 187, 2202&#x2013;2212.</Citation><ArticleIdList><ArticleId IdType="pubmed">21810613</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata M, Kurokawa D, Nakao H, Ohmura T and Aizawa S (2008) MicroRNA&#x2010;9 modulates Cajal&#x2010;Retzius cell differentiation by suppressing Foxg1 expression in mouse medial pallium. J Neurosci 28, 10415&#x2013;10421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671033</ArticleId><ArticleId IdType="pubmed">18842901</ArticleId></ArticleIdList></Reference><Reference><Citation>Leucht C, Stigloher C, Wizenmann A, Klafke R, Folchert A and Bally&#x2010;Cuif L (2008) MicroRNA&#x2010;9 directs late organizer activity of the midbrain&#x2010;hindbrain boundary. Nat Neurosci 11, 641&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">18454145</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaloy C, Liu L, Lee JA, Su H, Shen F, Yang GY, Young WL, Ivey KN and Gao FB (2010) MicroRNA&#x2010;9 coordinates proliferation and migration of human embryonic stem cell&#x2010;derived neural progenitors. Cell Stem Cell 6, 323&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2851637</ArticleId><ArticleId IdType="pubmed">20362537</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrzykowski AZ, Friesen RM, Martin GE, Puig SI, Nowak CL, Wynne PM, Siegelmann HT and Treistman SN (2008) Posttranscriptional regulation of BK channel splice variant stability by miR&#x2010;9 underlies neuroadaptation to alcohol. Neuron 59, 274&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714263</ArticleId><ArticleId IdType="pubmed">18667155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya&#x2010;Feldstein J, Reinhardt F, Onder TT, Valastyan S et al (2010) miR&#x2010;9, a MYC/MYCN&#x2010;activated microRNA, regulates E&#x2010;cadherin and cancer metastasis. Nat Cell Biol 12, 247&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2845545</ArticleId><ArticleId IdType="pubmed">20173740</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, Sun X, Guan Z, Zhang M and Duan M (2017) Modulation of influenza A virus replication by microRNA&#x2010;9 through targeting MCPIP1. J Med Virol 89, 41&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">27322373</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatro ET, Hefler S, Shumaker&#x2010;Armstrong S, Soontornniyomkij B, Yang M, Yermanos A, Wren N, Moore DJ and Achim CL (2013) Modulation of BK channel by MicroRNA&#x2010;9 in neurons after exposure to HIV and methamphetamine. J Neuroimmune Pharmacol 8, 1210&#x2013;1223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715589</ArticleId><ArticleId IdType="pubmed">23508624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai FW, Stephenson KB, Mahony J and Lichty BD (2014) Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF&#x2010;kappaB activation. J Virol 88, 54&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911702</ArticleId><ArticleId IdType="pubmed">24109243</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>